BR112014006741A2 - método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial - Google Patents

método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial

Info

Publication number
BR112014006741A2
BR112014006741A2 BR112014006741A BR112014006741A BR112014006741A2 BR 112014006741 A2 BR112014006741 A2 BR 112014006741A2 BR 112014006741 A BR112014006741 A BR 112014006741A BR 112014006741 A BR112014006741 A BR 112014006741A BR 112014006741 A2 BR112014006741 A2 BR 112014006741A2
Authority
BR
Brazil
Prior art keywords
kit
specific
kidney injury
urine sample
early
Prior art date
Application number
BR112014006741A
Other languages
English (en)
Portuguese (pt)
Inventor
Ernesto Irarrazabal Muñoz Carlos
Original Assignee
Univ Los Andes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47913944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014006741(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Los Andes filed Critical Univ Los Andes
Publication of BR112014006741A2 publication Critical patent/BR112014006741A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
BR112014006741A 2011-09-22 2011-09-22 método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial BR112014006741A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2011/054187 WO2013041913A1 (en) 2011-09-22 2011-09-22 Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage

Publications (1)

Publication Number Publication Date
BR112014006741A2 true BR112014006741A2 (pt) 2017-03-28

Family

ID=47913944

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014006741A BR112014006741A2 (pt) 2011-09-22 2011-09-22 método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial

Country Status (15)

Country Link
US (1) US20140329334A1 (enExample)
EP (1) EP2758774A4 (enExample)
JP (1) JP5893742B2 (enExample)
KR (1) KR20140076571A (enExample)
CN (1) CN103917869A (enExample)
AU (1) AU2011377379A1 (enExample)
BR (1) BR112014006741A2 (enExample)
CA (1) CA2849577A1 (enExample)
HK (1) HK1199754A1 (enExample)
IL (1) IL231626A0 (enExample)
IN (1) IN2014DN03194A (enExample)
MX (1) MX2014003422A (enExample)
PH (1) PH12014500650A1 (enExample)
RU (1) RU2014115999A (enExample)
WO (1) WO2013041913A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014182330A1 (en) 2013-05-06 2014-11-13 Hitachi Chemical Company Ltd Devices and methods for capturing target molecules
FR3014198B1 (fr) * 2013-12-03 2017-03-03 Biomerieux Sa Procede d'isolement d'exosomes
ES2825708T3 (es) * 2014-07-17 2021-05-17 Univ Pennsylvania Métodos para usar exosomas para monitorizar el estado de órgano trasplantado
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
JP2017534874A (ja) * 2014-11-11 2017-11-24 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物。
WO2016077537A1 (en) * 2014-11-12 2016-05-19 Hitachi Chemical Co., Ltd. Method and device for diagnosing organ injury
WO2016140388A1 (ko) * 2015-03-05 2016-09-09 경북대학교 산학협력단 엑소좀 또는 이의 단백질을 포함하는 장기 독성 진단용 바이오마커 조성물 및 이를 이용한 진단 방법
US20160320390A1 (en) * 2015-05-01 2016-11-03 Morehouse School Of Medicine Compositions and methods for capturing exosomes
ES2950426T3 (es) * 2015-08-12 2023-10-09 Univ Columbia Procedimientos de tratamiento de la depleción de volumen y la lesión renal
US11028443B2 (en) 2015-08-31 2021-06-08 Showa Denko Materials Co., Ltd. Molecular methods for assessing urothelial disease
JP6531987B2 (ja) * 2015-10-01 2019-06-19 国立大学法人名古屋大学 腎疾患診断のためのエクソソーム回収法
CN105441578B (zh) * 2016-01-19 2018-08-31 中南大学湘雅二医院 尿液外泌体microRNA分子标志物的应用及制备的试剂盒
JP7064665B2 (ja) 2016-03-07 2022-05-11 ファーザー フラナガンズ ボーイズ ホーム ドゥーイング ビジネス アズ ボーイズ タウン ナショナル リサーチ ホスピタル 非侵襲的分子対照
CN106053811A (zh) * 2016-06-05 2016-10-26 浙江大学 一种尿液外泌体elisa的检测方法及其应用
RU2647327C2 (ru) * 2016-07-05 2018-03-15 Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО КубГМУ Минздрава России) Способ ранней диагностики хронической болезни почек у пациентов с хронической обструктивной болезнью легких
JP2019168223A (ja) * 2016-08-12 2019-10-03 公立大学法人和歌山県立医科大学 エクソソームの膜に存在するタンパク質の検出方法
CN109425742A (zh) * 2017-08-23 2019-03-05 迪亚莱博(张家港)生物科技有限公司 一种化学发光法快速检测水通道蛋白1的试剂盒
JPWO2019045049A1 (ja) * 2017-09-01 2020-12-03 学校法人帝京大学 腎尿細管細胞特異的発現ベクター
RU2702023C1 (ru) * 2018-08-17 2019-10-04 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики острого повреждения почек после органосохраняющего хирургического лечения локализованного рака почки
ES2968898T3 (es) * 2019-06-06 2024-05-14 Fundacion Instituto De Investig Sanitaria Fundacion Jimenez Diaz Método in vitro para detectar enfermedad renal
EP3904883A1 (en) * 2020-04-07 2021-11-03 Sciomics GmbH Prediction and early diagnosis of acute kidney injury
RU2765678C1 (ru) * 2020-12-21 2022-02-01 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ прогнозирования риска развития острого повреждения почек у больных с острым коронарным синдромом
CN113189321B (zh) * 2021-04-12 2024-06-25 攸太科技(台州)有限公司 一种尿液检测方法
JP2025535454A (ja) * 2022-10-20 2025-10-24 コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション 腎臓病の早期診断のためのバイオマーカー組成物およびそれを用いた腎臓病の早期診断に必要な情報を提供する方法
KR20250003155A (ko) * 2023-06-30 2025-01-07 연세대학교 산학협력단 급성신손상의 회복에 대한 정보 제공 방법 및 이를 이용한 키트
CN116883739A (zh) * 2023-07-10 2023-10-13 中国医学科学院生物医学工程研究所 一种基于图像识别的尿隐血分类方法和系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
WO2004013152A2 (en) * 2002-08-06 2004-02-12 Duke University Novel targets for lithium therapy
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US8758991B2 (en) * 2006-04-26 2014-06-24 University Of Louisville Research Foundation, Inc. Isolation of membrane vesicles from biological fluids and methods of using same
DK2245199T3 (da) * 2008-02-01 2014-02-03 Gen Hospital Corp Anvendelse af mikrovesikler i diagnosticering, prognosticering og behandling af medicinske sygdomme og tilstande
US20110124519A1 (en) * 2008-03-18 2011-05-26 Frank Walter Falkenberg Method of assessing kidney function in a human subject
WO2010054025A1 (en) * 2008-11-05 2010-05-14 Abbott Laboratories Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use
JP2012508577A (ja) * 2008-11-12 2012-04-12 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 表現型を決定するためのエキソソームの使用方法およびそのシステム
RU2519722C2 (ru) * 2008-11-21 2014-06-20 Пхадиа Аб Способы, устройства и наборы для детекции или мониторинга острого повреждения почек
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
CA2800371C (en) * 2009-05-18 2018-01-02 Washington University Methods of renal cancer detection

Also Published As

Publication number Publication date
JP5893742B2 (ja) 2016-03-23
EP2758774A4 (en) 2015-04-29
IL231626A0 (en) 2014-05-28
WO2013041913A1 (en) 2013-03-28
MX2014003422A (es) 2014-10-13
AU2011377379A1 (en) 2014-04-10
PH12014500650A1 (en) 2014-06-02
EP2758774A1 (en) 2014-07-30
IN2014DN03194A (enExample) 2015-05-22
KR20140076571A (ko) 2014-06-20
CN103917869A (zh) 2014-07-09
US20140329334A1 (en) 2014-11-06
JP2014528076A (ja) 2014-10-23
RU2014115999A (ru) 2015-10-27
CA2849577A1 (en) 2013-03-28
HK1199754A1 (en) 2015-07-17

Similar Documents

Publication Publication Date Title
BR112014006741A2 (pt) método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial
WO2010057184A3 (en) Methods for detection of acute kidney injury in humans
PH12020551371A1 (en) Assays to detect neurodegeneration
ATE452343T1 (de) Verbesserte vitamin-d-messung
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
AU2018260845A1 (en) Evaluation and treatment of bradykinin-mediated disorders
BR112013027867A2 (pt) "método de detectar o nível de um anticorpo anti-ip10 em amostra, anticorpo monoclonal isolado ou porção de ligação de antígeno do mesmo, linhagem de célula de hibridoma e kit"
MX2018012580A (es) Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia.
BR112015021199A2 (pt) método para determinar se uma infeção é bacteriana e/ou viral, dispositivo de fluxo lateral para detecção de um analito em uma amostra, e, dispositivo para detecção de um marcador bacteriano e/ou viral em uma amostra
BR112013023540A2 (pt) anticorpo, kit e método para a determinação de peptídeos amilóides
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201290711A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
AR103935A1 (es) Métodos de detección y cuantificación de il-13 y sus usos en el diagnóstico y tratamiento de enfermedades asociadas a th-2
BR112013021963A2 (pt) sistema e método de separação de sangue para uma tira de teste seca
BR112014011818A2 (pt) método para realizar ensaios de quantificação
WO2008097773A8 (en) Methods and devices for diagnosis of appendicitis
WO2010099137A3 (en) In situ methods for monitoring the emt status of tumor cells in vivo
EP2569635A4 (en) METHOD FOR DIAGNOSIS AND / OR TREATMENT OF ENZEPHALITIS OR EPILEPSY
Jarius et al. Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
BR112016007037A2 (pt) método para detectar câncer pancreático, anticorpo monoclonal e kit
NZ594772A (en) Diagnosis and prognosis of renal injury and renal failure using vitamin k dependent protein c
JP2017505897A5 (enExample)
BR112016017926A2 (pt) ensaio para detectar periostina humana
RU2013158667A (ru) Способ диагностики болезни гоше

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]